We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$9.73B
1-Year Est. Return
55.65%
This Fund
S&P 500
This Quarter
Est. Return
+8.35%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$14.1B
AUM Growth
+$375M
(+2.7%)
Cap. Flow
-$250M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
13.15%
Holding
353
New
42
Increased
77
Reduced
179
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PR
Permian Resources
PR
|
+$81.4M |
| 2 |
TSRO
TESARO, Inc.
TSRO
|
+$73.9M |
| 3 |
BWX Technologies
BWXT
|
+$60.6M |
| 4 |
WP
Worldpay, Inc.
WP
|
+$54.3M |
| 5 |
FMC
FMC
|
+$47M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BERY
Berry Global Group, Inc.
BERY
|
+$72.3M |
| 2 |
Acadia Healthcare
ACHC
|
+$66.2M |
| 3 |
Euronet Worldwide
EEFT
|
+$62.9M |
| 4 |
SEI Investments
SEIC
|
+$58.9M |
| 5 |
Dana Inc
DAN
|
+$54.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Industrials | 17.68% |
| 3 | Healthcare | 14.49% |
| 4 | Financials | 13.33% |
| 5 | Consumer Discretionary | 10.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Alnylam Pharmaceuticals
ALNY
$38.3B
| $3.56M | 0.03% |
36,200
+9,164
| +34% | +$909K |
|
|
ZUO
277
DELISTED
Zuora, Inc.
ZUO
| $3.34M | 0.02% |
+122,933
| New | +$2.91M |
|
278
CRISPR Therapeutics
CRSP
$4.69B
| $3.21M | 0.02% |
+54,631
| New | +$3.11M |
|
|
PVTL
279
DELISTED
Pivotal Software, Inc.
PVTL
| $3.11M | 0.02% |
+128,254
| New | +$2.64M |
|
280
Aqua Metals
AQMS
$9.78M
| $2.98M | 0.02% |
5,183
-155
| -3% | -$95.3K |
|
|
CTRL
281
DELISTED
Control4 Corporation
CTRL
| $2.71M | 0.02% |
111,552
-291,025
| -72% | -$6.8M |
|
|
ESV
282
DELISTED
Ensco Rowan plc
ESV
| $2.7M | 0.02% |
+93,022
| New | +$2.28M |
|
283
WIX.com
WIX
$2.56B
| $2.6M | 0.02% |
25,903
-67,069
| -72% | -$5.98M |
|
284
Nutanix
NTNX
$16.1B
| $2.47M | 0.02% |
47,809
+24,657
| +107% | +$1.36M |
|
285
Agios Pharmaceuticals
AGIO
$2.08B
| $2.28M | 0.02% |
27,037
-129,104
| -83% | -$11.3M |
|
|
SAIL
286
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $2.27M | 0.02% |
+92,405
| New | +$2.25M |
|
287
PTC Therapeutics
PTCT
$6.18B
| $1.9M | 0.01% |
56,282
-583,999
| -91% | -$18.2M |
|
288
MongoDB
MDB
$25.8B
| $1.87M | 0.01% |
37,622
-399,454
| -91% | -$17.9M |
|
289
Neuronetics
STIM
$127M
| $1.86M | 0.01% |
+69,757
| New | +$1.9M |
|
|
ADAP
290
DELISTED
Adaptimmune Therapeutics
ADAP
| $1.84M | 0.01% |
+154,885
| New | +$1.93M |
|
|
MODN
291
DELISTED
MODEL N, INC.
MODN
| $1.52M | 0.01% |
+81,954
| New | +$1.44M |
|
|
COUP
292
DELISTED
Coupa Software Incorporated
COUP
| $1.3M | 0.01% |
20,877
-278,974
| -93% | -$14.8M |
|
|
ZEN
293
DELISTED
ZENDESK INC
ZEN
| $1.26M | 0.01% |
23,207
-233,716
| -91% | -$12.4M |
|
|
WBT
294
DELISTED
Welbilt, Inc.
WBT
| $1.15M | 0.01% |
51,531
-88,439
| -63% | -$1.77M |
|
295
Precigen
PGEN
$1.94B
| $1.08M | 0.01% |
77,461
-447,711
| -85% | -$7.56M |
|
296
iRhythm Holdings
IRTC
$4.02B
| $1.04M | 0.01% |
+12,770
| New | +$893K |
|
297
LSI Industries
LYTS
$834M
| $511K | ﹤0.01% |
95,684
-842,140
| -90% | -$5.12M |
|
|
EVOP
298
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $150K | ﹤0.01% |
+7,311
| New | +$153K |
|
299
Acadia Pharmaceuticals
ACAD
$4.51B
| – | – |
-289,443
| Closed | -$6.5M |
|
300
Adeia
ADEA
$2.55B
| – | – |
-2,586,144
| Closed | -$14.5M |
|
Similar funds
HL
DCP
CCM
URS
CIM
MPI
TIM
DPIM
Frontier Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Frontier Capital Management held 353 positions worth $14.1B, up 2.7% from $13.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Frontier Capital Management's Q2 2018 filing shows 42 new, 77 increased, 179 reduced and 55 closed positions. Its largest new stake was Permian Resources: 4,500,024 shares worth $81.3M. The largest sale was Berry Global Group, Inc., an estimated $72.3M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.
- Frontier Capital Management's largest Q2 2018 buy was Permian Resources: 4,500,024 shares worth $81.3M.
- Frontier Capital Management added most to TESARO, Inc. in Q2 2018, an estimated $73.9M increase.
- Frontier Capital Management's biggest Q2 2018 reduction was Berry Global Group, Inc., cutting an estimated $72.3M.
- Frontier Capital Management fully exited SEI Investments in Q2 2018, selling an estimated $58.9M.
- Frontier Capital Management's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2018.
- Frontier Capital Management opened 42 new positions and closed 55 in Q2 2018.
- Frontier Capital Management's portfolio value rose 2.7% quarter-over-quarter to $14.1B.
Based on Frontier Capital Management's 13F filing for Q2 2018, filed 3 Aug 2018.